Thyroid Cancer: Role of RET and Beyond
Author(s) -
Francesca Carlomagno
Publication year - 2012
Publication title -
european thyroid journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.23
H-Index - 10
eISSN - 2235-0802
pISSN - 2235-0640
DOI - 10.1159/000336975
Subject(s) - medicine , carcinogenesis , thyroid carcinoma , medullary thyroid cancer , proto oncogene proteins c ret , thyroid cancer , cancer research , multiple endocrine neoplasia type 2 , medullary cavity , thyroid , gene , medullary carcinoma , cancer , mutation , pathology , genetics , germline mutation , biology , receptor , glial cell line derived neurotrophic factor , neurotrophic factors
Specific thyroid cancer histotypes, such as papillary and medullary thyroid carcinoma, display genetic rearrangements or point mutations of the RET gene, resulting in its oncogenic conversion. The molecular mechanisms mediating RET rearrangement with other genes and the role of partner genes in tumorigenesis have been described. In addition, the RET protein has become a molecular target for medullary thyroid carcinoma treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom